Skip to content

    Recently Viewed

      Listening...

      Home / Media Center / Press releases / Financial /
      Johnson & Johnson to Participate in the 2017 UBS Global Healthcare Conference

      Johnson & Johnson to Participate in the 2017 UBS Global Healthcare Conference

      Share Article
      share to

      NEW BRUNSWICK, N.J., May 5, 2017 /PRNewswire/ -- Johnson & Johnson (NYSE: JNJ) will participate in the 2017 UBS Global Healthcare Conference on Tuesday, May 23, at the Grand Hyatt New York. Dominic Caruso, Executive Vice President, Chief Financial Officer will represent the Company in a session scheduled at 10:00 a.m. (Eastern Time).

      This webcast will be available to investors and other interested parties by accessing the Johnson & Johnson website at www.investor.jnj.com.

      A webcast and podcast replay will be available approximately two hours after the live webcast.

      SOURCE Johnson & Johnson

      Ernie Knewitz, (732) 524-6623, (917) 697-2318 (M); Amy Jo Meyer, (732) 524-6678, (908) 616-6250 (M); Investor Contacts, Joseph J. Wolk, (732) 524-1142; Jason Valmore, (732) 524-3709

      You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.